Skip to main content
. 2016 Oct 26;57(4):513–523. doi: 10.1002/jcph.832

Figure 3.

Figure 3

Geometric mean percentage (±95% confidence intervals) changes from baseline in (A) proprotein convertase subtilisin kexin type 9 (PCSK9) and (B) ultracentrifugation (UC) low‐density lipoprotein cholesterol (LDL‐C) by degree of hepatic impairment.

HHS Vulnerability Disclosure